Merck CEO Wants to See Japan’s Shift to Pro-Innovation Structure in 2024 Reform

Merck CEO Robert Davis Meets the Press in Tokyo Japan should revisit the slew of drug pricing rule changes made over the past years and introduce mechanisms to support innovation in the 2024 reform, Merck CEO Robert Davis urged in...read more